Showing results (71-80 of 206) with videos related to
Sort By:
Pageof 21
Leukemia Research|February 8, 2025
Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML)Zena Komrokji, Najla Al Ali, Zhuoer Xie, et al.Leukemia & Lymphoma|June 11, 2021
What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?Rami Komrokji, Najla Al Ali, Eric Padron, et al.Journal of Virology|March 30, 2005
Structure of adeno-associated virus type 4Eric Padron, Valorie Bowman, Nikola Kaludov, et al.Clinical Lymphoma, Myeloma & Leukemia|June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid LeukemiaDasom Lee, Akriti G Jain, Yehuda Deutsch, et al.Clinical Lymphoma, Myeloma & Leukemia|March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older PatientsMegan Melody, Andrew Kuykendall, David Sallman, et al.Journal of Virology|August 31, 2007
Structure of adeno-associated virus serotype 8, a gene therapy vectorHyun-Joo Nam, Michael Douglas Lane, Eric Padron, et al.Clinical Lymphoma, Myeloma & Leukemia|April 20, 2025
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease ProgressionLuis E Aguirre, Somedeb Ball, Akriti Jain, et al.Clinical Lymphoma, Myeloma & Leukemia|August 9, 2023
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid LeukemiaAkriti G Jain, Somedeb Ball, Luis E Aguirre, et al.Clinical Lymphoma, Myeloma & Leukemia|October 23, 2020
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase KaryotypeZaker I Schwabkey, Najla Al Ali, Onyee Chan, et al.Cancer|August 9, 2022
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlatesAndrew T Kuykendall, Qianxing Mo, David A Sallman, et al.Pageof 21